Trial Profile
BMI Evaluation: Placebo and Active Comparator Trial of Olanzapine Zydis Pills Used Sublingually (PLATYPUS).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Olanzapine
- Indications Bipolar disorders; Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- Acronyms PLATYPUS
- Sponsors Eli Lilly and Company
- 28 Sep 2008 Actual number of patients enrolled was 151 according to the ClinicalTrials.gov record.
- 11 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 19 Nov 2007 Status changed from recruiting to in progress.